Evidence map›Paper›PMID 18398593›Full record

ReviewJournal of molecular medicine (Berlin, Germany)2008

AT1-receptor autoantibodies and uteroplacental RAS in pregnancy and pre-eclampsia.

Florian Herse, Anne Cathrine Staff, Lydia Hering, Dominik N Müller, Friedrich C Luft, Ralf Dechend

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of molecular medicine (Berlin, Germany), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Systemic Outcomes of (PyrScientific reports · 2019
    Article
  9. Article
  10. Article
  11. B Regulatory Cells: Players in Pregnancy and Early Life.International journal of molecular sciences · 2018
    Review
  12. Review
  13. Downregulation of apelin in the human placental chorionic villi from preeclamptic pregnancies.American journal of physiology. Endocrinology and metabolism · 2015
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Florian HerseMedical Faculty of the Charité, Franz-Volhard Clinic, HELIOS Clinic, Berlin, Germany.
Anne Cathrine Staff
Lydia Hering
Dominik N Müller
Friedrich C Luft
Ralf Dechend

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pre-eclampsia is a common, pregnancy-induced disorder, consisting of hypertension and proteinuria. The condition is one of the leading causes for maternal and perinatal morbidity and mortality. Nonetheless, the underlying molecular mechanisms remain unclear. Immunological mechanisms and the renin-angiotensin system have been implicated in the development of pre-eclampsia. Agonistic autoantibodies to the angiotensin II type I receptor (AT1-AA) have been identified in pre-eclamptic patients, unifying the two hypothesis. Evidence has also accumulated for the existence and importance of a local, utroplacental renin-angiotensin system. We summarize recent data emphasizing the pathophysiological role for the autoantibodies and the uteroplacental renin-angiotensin system.

Indexed as

AnimalsAutoantibodiesFemaleHumansPlacental CirculationPre-EclampsiaPregnancyReceptor, Angiotensin, Type 1Renin-Angiotensin SystemVascular Endothelial Growth Factor Receptor-1AutoantibodiesReceptor, Angiotensin, Type 1Vascular Endothelial Growth Factor Receptor-1

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.